Research
Healing by Context: Placebo Effects Across Psychological and Somatic Dimensions
by Karin Meissner1
¹Institute of Applied Health Sciences, Faculty of Applied Natural Sciences and Health, Coburg University of Applied Sciences and Arts, 96450 Coburg, Germany
Cite as: Meissner, K. (2026). Healing by Context: Placebo Effects Across Psychological and Somatic Dimensions. THE MIND Bulletin on Mind-Body Medicine Research, 10(1), 8-13. https://10.61936/themind/202603133
Abstract
Placebo effects demonstrate how contextual factors surrounding medical treatments can shape therapeutic outcomes. Research shows that external treatment cues, such as the clinical setting,
treatment rituals, and verbal suggestions, as well as internal processes including expectations, emotions, and prior experiences, can modulate treatment responses across multiple domains such as
pain, nausea, and appetite regulation. Growing evidence also indicates that placebo effects are accompanied by measurable physiological changes, ranging from alterations in neural activity within
specific brain regions to modulation of endocrine, autonomic, and immune processes. This article examines how the therapeutic context influences healing responses across psychological and somatic
dimensions. It argues that placebo effects can be understood as embodied processes in which cognitive meaning, social interaction, and biological regulation dynamically interact. Recognizing
these mechanisms has important implications for clinical practice, as optimizing the therapeutic context can enhance the effectiveness of medical treatments.
Keywords: Placebo Effects, Therapeutic Context, Expectation, Mind–Body Interaction, Psychobiological Mechanisms
Healing by Context
When discussing placebo effects, we are essentially addressing the interaction between mind and body. Placebo research therefore offers a unique window into how psychological processes can
translate into physiological change.
One of the most compelling demonstrations of the clinical placebo effect comes from studies comparing the open versus hidden administration of analgesic drugs. In a landmark experiment,
postoperative pain patients received identical analgesic medication under two conditions (Colloca et al., 2004). In the open condition, patients were informed that they were receiving a
painkiller. In the hidden condition, the same medication was delivered via an automated infusion pump without the patient’s awareness. Despite identical pharmacological input, pain decreased more
rapidly and more strongly when patients knew they were receiving treatment. The difference between these two conditions reflects the placebo component of the analgesic effect. The study
illustrates that pharmacological treatments do not act in isolation; rather, their effectiveness is shaped by the context in which they are delivered.
Experimental placebo research has identified several mechanisms through which contextual factors influence symptoms (Schedlowski et al., 2015). Verbal suggestions can generate expectations of
improvement or deterioration, thereby eliciting placebo or nocebo responses. Learning processes, such as classical conditioning and social observational learning, can further reinforce these
expectations through prior treatment experiences. In addition, interpersonal factors within the clinician-patient relationship, such as empathy and warmth, may enhance placebo responses under
certain conditions. Together, these elements constitute the therapeutic context: a dynamic interplay between external cues and internal processes (Wager & Atlas, 2015). Through this
interaction, the therapeutic context shapes how symptoms such as pain or nausea are experienced.
Expectations as Drivers of Placebo Effects
Among the contextual mechanisms underlying placebo responses, expectations play a particularly central role. A meta-analysis of placebo analgesia studies showed that verbal suggestions about
treatment effectiveness can reliably induce placebo analgesia in both experimental and clinical settings (Peerdeman et al., 2016). Importantly, mediation analyses indicate that positive
expectations directly predict the magnitude of symptom improvement. In other words, verbal suggestions influence pain primarily by shaping what patients expect will happen.
In experimental studies, placebo effects are often induced using classical conditioning paradigms in which participants repeatedly experience symptom relief after receiving a (supposedly) active
treatment. Over time, the contextual cues associated with the treatment become sufficient to trigger the response even in the absence of an active intervention. Social observational learning
provides another powerful mechanism through which placebo effects can emerge. Seeing another individual benefit from a (placebo) treatment can generate similar expectations and symptom changes in
observers.
Meta-analytic comparisons of these three different placebo induction methods show that verbal suggestions alone typically produce small-to-medium placebo effects (Blythe et al., 2023). When
combined with conditioning or observational learning, however, effect sizes increase to the medium range. These findings suggest that expectations become particularly powerful when reinforced by
positive treatment experiences, whether directly experienced or observed in others.
The Meaning of the Treatment Ritual
Beyond expectations and learning processes, the characteristics of the treatment itself also influence placebo responses. Medical interventions carry symbolic meaning. In a meta-analysis of 78
placebo-controlled trials of migraine prophylaxis, placebo response rates varied markedly depending on the type of placebo intervention (Meissner et al., 2013). Sham surgery and sham acupuncture
produced significantly larger improvements than placebo pills. Network meta-analyses further showed that sham acupuncture achieved effects comparable to pharmacological migraine prophylaxis.
One explanation for these differences is that more elaborate or invasive procedures evoke stronger expectations of effectiveness. A survey assessing public expectations of pain treatments
supports this interpretation. When individuals rated the expected effectiveness of different treatment routes, injections were typically perceived as more potent than oral medications or topical
creams (Peerdeman et al., 2018). Interestingly, these expectations were symptom-specific. For example, topical ointments generated the strongest expectations for treating itch, but not for
treating pain. In other words, the route of administration that appears most plausible for a given symptom tends to evoke the strongest treatment expectations. What role do sensory cues play in
placebo effects? In a placebo study on nausea, participants received sham stimulation from a device either with or without additional tactile stimulation, combined with positive verbal
suggestions (Aichner et al., 2019).Notably, adding tactile stimulation did not enhance the placebo effect during the experiment but significantly increased the perceived credibility and
effectiveness of the treatment afterward.
These findings suggest that sensory cues may shape how convincing a treatment appears, thereby influencing expectations in future therapeutic encounters.
Stress and the Internal Context
While external contextual cues are crucial, internal states also shape placebo responses. Stress is a particularly important factor, as it frequently occurs in clinical contexts. Activation of
the hypothalamic-pituitary-adrenal (HPA) axis during stress elevates cortisol levels and alters neural circuits involved in reward processing and expectation formation (Colloca et al., 2004).
Emotional distress may therefore shift the brain from a predictive mode to a defensive mode, potentially limiting the capacity to generate placebo responses.
A large cohort study supports this view (Wang et al., 2022). Negative emotional states such as anxiety, depression, and pain-related catastrophizing were associated with reduced placebo analgesia
in an experimental placebo paradigm. In contrast, traits such as reward sensitivity, empathy, and openness predicted stronger placebo effects.
The relationship between acute stress and placebo effects appears more complex, and experimental studies have so far produced inconsistent findings. For example, acute stress has been shown to
increase susceptibility to expectation-driven effects in a visceral pain paradigm, with stress enhancing both placebo and nocebo responses (Roderigo et al., 2017). In contrast, in an experimental
nausea paradigm combining stress induction with placebo treatment, participants exposed to acute stress reported reductions in nausea similar to those observed in non-stressed participants,
suggesting no effect of stress on subjective placebo responses (Jacob et al., 2023). However, only in the non-stressed group was the placebo effect on nausea accompanied by improvements in
gastric activity, whereas acute stress abolished this gastric placebo effect.
From Brain to Body: Biological Mechanisms
Evidence suggests that placebo mechanisms operate across multiple biological levels. At the neural level, the prefrontal cortex plays a central role in expectation formation. The dorsolateral
prefrontal cortex generates and maintains predictions about treatment outcomes and modulates downstream brain regions involved in pain processing (Crawford et al., 2021; van der Meulen et al.,
2017). Disrupting this region can abolish placebo analgesia without affecting baseline pain perception (Krummenacher et al., 2010). Besides placebo analgesia, neural mechanisms have also been
studied in other systems, such as appetite regulation. While experimental studies show that verbal suggestions about hunger and satiety can rapidly alter subjective hunger ratings and food
cravings (Hoffmann et al., 2018; Lanz et al., 2024), neuroimaging data demonstrate that prefrontal regions again play a crucial role in mediating these expectation-driven effects (Khalid et al.,
2024).
Beyond neural mechanisms, placebo responses can also manifest at the molecular level. Proteomic analyses in an experimental nausea model revealed that placebo interventions modulated proteins
associated with inflammatory pathways, including components of the acute-phase response and the complement system (Meissner et al., 2020). Interestingly, some protein signatures predictive of
placebo responsiveness were linked to biological pathways involved in social bonding. Molecules associated with neural connectivity and affiliative behavior may thus reflect evolutionary
mechanisms connecting caregiving, social interaction, and physiological regulation. Such findings support the idea that placebo effects may have deep evolutionary roots in social mechanisms of
attachment and bonding (Benedetti, 2021).
Toward an Integrated Model of Embodied Healing
Taken together, current placebo research points toward an integrated model of embodied healing. In this model, contextual information, such as expectations, treatment rituals, and interpersonal
signals, is interpreted by the brain and translated into physiological responses across neural, autonomic, endocrine, and immune systems in the body (Fig. 1).
Several implications follow from this perspective. First, the therapeutic ritual itself should be recognized as a biologically active component of treatment. The way a therapy is framed,
delivered, and experienced can influence treatment outcomes. Second, stress reduction may be essential for optimizing treatment responses, as stress can interfere with neural circuits that
support placebo mechanisms, although further research is needed to clarify this relationship. Finally, expectations should be understood not merely as beliefs but as biological forces capable of
triggering cascades across multiple physiological systems. Ultimately, placebo effects remind us that meaning, context, and human connection are not peripheral to medicine but form part of its
biological foundation.
Fig. 1. Multilevel pathways of contextual healing. Conceptual model illustrating how contextual factors associated with medical treatment can generate healing responses across
multiple biological levels. External cues, such as verbal suggestions, treatment rituals, and interpersonal interactions, shape expectations and cognitive processes in the brain. These processes
engage neural circuits in the prefrontal cortex (PFC), which in turn modulate downstream physiological systems including autonomic regulation, hormonal signaling, and molecular pathways involved
in inflammation and immune responses. Through these interconnected pathways, contextual information is translated into measurable changes in symptoms and physiology.
Authorship Contribution Statement: Single author.
Funding: This research received no external funding.
Data Availability Statement: No data was used in this review article.
Conflicts of Interest: The authors declare no conflicts of interest.
References
Aichner, S., Haile, A., Hoffmann, V., Olliges, E., Tschöp, M. H., & Meissner, K. (2019). The role of tactile stimulation for expectation, perceived treatment assignment and the placebo effect in an experimental nausea paradigm. Frontiers in neuroscience, 13, 1212. https://doi.org/10.3389/fnins.2019.01212
Benedetti, F. (2021). Placebo effects: understanding the mechanisms in health and disease. Oxford University Press.
Blythe, J. S., Thomaidou, M. A., Peerdeman, K. J., van Laarhoven, A. I., Van Schothorst, M. M., Veldhuijzen, D. S., & Evers, A. W. (2023). Placebo effects on cutaneous pain and itch: a systematic review and meta-analysis of experimental results and methodology. Pain, 164(6), 1181–1199. https://doi.org/10.1097/j.pain.0000000000002820
Colloca, L., Lopiano, L., Lanotte, M., & Benedetti, F. (2004). Overt versus covert treatment for pain, anxiety, and Parkinson's disease. The Lancet Neurology, 3(11), 679–684. https://doi.org/10.1016/S1474-4422(04)00908-1
Crawford, L. S., Mills, E. P., Hanson, T., Macey, P. M., Glarin, R., Macefield, V. G., Keay, K. A., & Henderson, L. A. (2021). Brainstem mechanisms of pain modulation: a within-subjects 7T fMRI study of placebo analgesic and nocebo hyperalgesic responses. Journal of Neuroscience, 41(47), 9794–9806. https://doi.org/10.1523/JNEUROSCI.0806-21.2021
Hoffmann, V., Lanz, M., Mackert, J., Muller, T., Tschop, M., & Meissner, K. (2018). Effects of Placebo Interventions on Subjective and Objective Markers of Appetite-A Randomized Controlled Trial. Front Psychiatry, 9, 706. https://doi.org/10.3389/fpsyt.2018.00706
Jacob, C., Olliges, E., Haile, A., Hoffmann, V., Jacobi, B., Steinkopf, L., Lanz, M., Wittmann, M., Tschöp, M. H., & Meissner, K. (2023). Placebo effects on nausea and motion sickness are resistant to experimentally-induced stress. Scientific Reports, 13(1), 9908. https://doi.org/10.1038/s41598-023-36296-w
Khalid, I., Rodrigues, B., Dreyfus, H., Frileux, S., Meissner, K., Fossati, P., Hare, T. A., & Schmidt, L. (2024). Mapping expectancy-based appetitive placebo effects onto the brain in women. Nat Commun, 15(1), 248. https://doi.org/10.1038/s41467-023-44569-1
Krummenacher, P., Candia, V., Folkers, G., Schedlowski, M., & Schönbächler, G. (2010). Prefrontal cortex modulates placebo analgesia. PAIN®, 148(3), 368–374. https://doi.org/10.1016/j.pain.2009.09.033
Lanz, M., Hoffmann, V., & Meissner, K. (2024). Satiety-enhancing placebo intervention decreases selective attention to food cues. Frontiers in Psychiatry, 15, 1472532. https://doi.org/10.3389/fpsyt.2024.1472532
Meissner, K., Fässler, M., Rücker, G., Kleijnen, J., Hróbjartsson, A., Schneider, A., Antes, G., & Linde, K. (2013). Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA internal medicine, 173(21), 1941–1951. https://doi.org/10.1001/jamainternmed.2013.10391
Meissner, K., Lutter, D., von Toerne, C., Haile, A., Woods, S. C., Hoffmann, V., Ohmayer, U., Hauck, S. M., & Tschoep, M. H. (2020). Molecular classification of the placebo effect in nausea. PloS one, 15(9), e0238533. https://doi.org/10.1371/journal.pone.0238533
Peerdeman, K., Tekampe, J., Van Laarhoven, A., van Middendorp, H., Rippe, R., Peters, M., & Evers, A. (2018). Expectations about the effectiveness of pain‐and itch‐relieving medication administered via different routes. European Journal of Pain, 22(4), 774–783. https://doi.org/10.1002/ejp.1163
Peerdeman, K. J., van Laarhoven, A. I., Keij, S. M., Vase, L., Rovers, M. M., Peters, M. L., & Evers, A. W. (2016). Relieving patients' pain with expectation interventions: a meta-analysis. Pain, 157(6), 1179–1191. https://doi.org/10.1097/j.pain.0000000000000540
Roderigo, T., Benson, S., Schöls, M., Hetkamp, M., Schedlowski, M., Enck, P., & Elsenbruch, S. (2017). Effects of acute psychological stress on placebo and nocebo responses in a clinically relevant model of visceroception. Pain, 158(8), 1489–1498. https://doi.org/10.1097/j.pain.0000000000000940
Schedlowski, M., Enck, P., Rief, W., & Bingel, U. (2015). Neuro-bio-behavioral mechanisms of placebo and nocebo responses: implications for clinical trials and clinical practice. Pharmacological reviews, 67(3), 697–730. https://doi.org/10.1124/pr.114.009423
van der Meulen, M., Kamping, S., & Anton, F. (2017). The role of cognitive reappraisal in placebo analgesia: an fMRI study. Social Cognitive and Affective Neuroscience, 12(7), 1128–1137. https://doi.org/10.1093/scan/nsx033
Wager, T. D., & Atlas, L. Y. (2015). The neuroscience of placebo effects: connecting context, learning and health. Nature Reviews Neuroscience, 16(7), 403–418. https://doi.org/10.1038/nrn3976
Wang, Y., Chan, E., Dorsey, S. G., Campbell, C. M., & Colloca, L. (2022). Who are the placebo responders? A cross-sectional cohort study for psychological determinants. Pain, 163(6), 1078–1090. https://doi.org/10.1097/j.pain.0000000000002478
